Form4insider filings, from the source

SEC Form 4 · accession 0001140361-16-063633

HALOZYME THERAPEUTICS, INC. · HALO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Randal J Kirk
Director · 10% Owner
Period of report
May 4, 2016
Accepted (ET)
May 5, 2016 · 7:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001159036

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 4, 2016A20,202$0.00A3,538,253D
Common StockF2holding———2,685,415Iby R.J. Kirk DOT
Common StockF2holding———263,200Iby JPK 2012
Common StockF2holding———42,319Iby Kellie L. Banks LTT
Common StockF2holding———3,977,445Iby Kapital Joe
Common StockF2holding———331,395Iby JPK 2009
Common StockF2holding———331,394Iby MGK 2009
Common StockF2holding———293,000Iby JPK 2008
Common StockF2holding———293,000Iby MGK 2008
Common StockF2holding———293,000Iby ZSK 2008
Common StockF2holding———10,945Iby Lotus Capital
Common StockF2holding———135,000Iby Staff 2001
Common StockF2holding———1,326,320Iby NRM IV
Common StockF2holding———6,328,853Iby NRM V

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses